Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer (ACBC) reduced the side effects associated with cognitive impairment. We evaluated the effects of melatonin on cognition...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Palmer, Ana Claudia Souza, Zortea, Maxciel, Souza, Andressa, Santos, Vinicius, Biazús, Jorge Villanova, Torres, Iraci L. S., Fregni, Felipe, Caumo, Wolnei
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164654/
https://ncbi.nlm.nih.gov/pubmed/32302347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0231379
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki